End-stage Kidney Disease Clinical Trials in Minneapolis, Minnesota
2 recruitingMinneapolis, Minnesota
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Phase 3
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
End Stage Renal DiseaseEnd-stage Kidney Disease
VA Office of Research and Development2,540 enrolled8 locationsNCT05931276